Back

Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Electrocardiography + cardioversion Electrocardiography ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Anca Rodica Dan

Colentina Clinical Hospital Carol Davila University of Medicine and Pharmacy, Bucharest (Romania)

29 More presentations in this session

Presentation thumbnail
The CHA2DS2-VASc - score and sex as predictors of thromboembolic complications in cardioversion of acute atrial fibrillation.
Ms A. Bah (Kuopio, FI)
Abstract
Presentation thumbnail
Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study
Professor J. Merino (Madrid, ES)
Abstract
Presentation thumbnail
Specific ECG signs of LMNA-associated dilated cardiomyopathy
Doctor T. Vaikhanskaya (Minsk, BY)
Abstract Slides
Presentation thumbnail
Prevalence and prognostic significance of negative U-waves in the 12-lead electrocardiogram in the general population
Doctor A. Holkeri (Lahti, FI)
Abstract Slides
Presentation thumbnail
The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study
Professor G. Lip (Liverpool, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Electrocardiography + cardioversion

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources